ORASURE TECHNOLOGIES INC (OSUR) Stock Fundamental Analysis

NASDAQ:OSUR • US68554V1089

2.8 USD
+0.05 (+1.82%)
Last: Feb 24, 2026, 01:23 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to OSUR. OSUR was compared to 185 industry peers in the Health Care Equipment & Supplies industry. OSUR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. OSUR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • OSUR had negative earnings in the past year.
  • In the past year OSUR has reported a negative cash flow from operations.
  • In the past 5 years OSUR reported 4 times negative net income.
  • In multiple years OSUR reported negative operating cash flow during the last 5 years.
OSUR Yearly Net Income VS EBIT VS OCF VS FCFOSUR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

  • With a Return On Assets value of -14.24%, OSUR perfoms like the industry average, outperforming 57.30% of the companies in the same industry.
  • With a decent Return On Equity value of -16.64%, OSUR is doing good in the industry, outperforming 62.16% of the companies in the same industry.
Industry RankSector Rank
ROA -14.24%
ROE -16.64%
ROIC N/A
ROA(3y)1.01%
ROA(5y)-1.05%
ROE(3y)0.93%
ROE(5y)-1.4%
ROIC(3y)N/A
ROIC(5y)N/A
OSUR Yearly ROA, ROE, ROICOSUR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

  • Looking at the Gross Margin, with a value of 40.41%, OSUR is doing worse than 67.57% of the companies in the same industry.
  • In the last couple of years the Gross Margin of OSUR has declined.
  • OSUR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 40.41%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.22%
GM growth 5Y-6.88%
OSUR Yearly Profit, Operating, Gross MarginsOSUR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • OSUR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for OSUR has been increased compared to 1 year ago.
  • OSUR has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, OSUR has an improved debt to assets ratio.
OSUR Yearly Shares OutstandingOSUR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
OSUR Yearly Total Debt VS Total AssetsOSUR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

  • An Altman-Z score of 1.91 indicates that OSUR is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • OSUR has a Altman-Z score (1.91) which is in line with its industry peers.
  • A Debt/Equity ratio of 0.00 indicates that OSUR is not too dependend on debt financing.
  • OSUR has a better Debt to Equity ratio (0.00) than 74.59% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.91
ROIC/WACCN/A
WACC9.91%
OSUR Yearly LT Debt VS Equity VS FCFOSUR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 7.03 indicates that OSUR has no problem at all paying its short term obligations.
  • OSUR has a Current ratio of 7.03. This is amongst the best in the industry. OSUR outperforms 85.95% of its industry peers.
  • OSUR has a Quick Ratio of 6.20. This indicates that OSUR is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 6.20, OSUR belongs to the top of the industry, outperforming 87.57% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 7.03
Quick Ratio 6.2
OSUR Yearly Current Assets VS Current LiabilitesOSUR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • The earnings per share for OSUR have decreased strongly by -633.33% in the last year.
  • The Revenue for OSUR has decreased by -43.95% in the past year. This is quite bad
  • The Revenue has been growing slightly by 3.75% on average over the past years.
EPS 1Y (TTM)-633.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-216.67%
Revenue 1Y (TTM)-43.95%
Revenue growth 3Y-7.36%
Revenue growth 5Y3.75%
Sales Q2Q%-32.14%

3.2 Future

  • Based on estimates for the next years, OSUR will show a very strong growth in Earnings Per Share. The EPS will grow by 25.37% on average per year.
  • OSUR is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -4.62% yearly.
EPS Next Y-239.35%
EPS Next 2Y-72.67%
EPS Next 3Y-41.36%
EPS Next 5Y25.37%
Revenue Next Year-38.37%
Revenue Next 2Y-20.05%
Revenue Next 3Y-11.49%
Revenue Next 5Y-4.62%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
OSUR Yearly Revenue VS EstimatesOSUR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
OSUR Yearly EPS VS EstimatesOSUR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • OSUR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year OSUR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OSUR Price Earnings VS Forward Price EarningsOSUR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OSUR Per share dataOSUR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

  • A cheap valuation may be justified as OSUR's earnings are expected to decrease with -41.36% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-72.67%
EPS Next 3Y-41.36%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • OSUR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ORASURE TECHNOLOGIES INC

NASDAQ:OSUR (2/24/2026, 1:23:58 PM)

2.8

+0.05 (+1.82%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-05
Earnings (Next)02-25
Inst Owners90.28%
Inst Owner Change-3.94%
Ins Owners5.58%
Ins Owner Change0.29%
Market Cap200.84M
Revenue(TTM)125.70M
Net Income(TTM)-60.24M
Analysts80
Price Target4.59 (63.93%)
Short Float %5.77%
Short Ratio6.46
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-11.19%
Min EPS beat(2)-24.34%
Max EPS beat(2)1.96%
EPS beat(4)1
Avg EPS beat(4)-41.25%
Min EPS beat(4)-142.2%
Max EPS beat(4)1.96%
EPS beat(8)4
Avg EPS beat(8)-77.07%
EPS beat(12)8
Avg EPS beat(12)182.53%
EPS beat(16)9
Avg EPS beat(16)134.8%
Revenue beat(2)1
Avg Revenue beat(2)-3.97%
Min Revenue beat(2)-8.84%
Max Revenue beat(2)0.89%
Revenue beat(4)2
Avg Revenue beat(4)-1.85%
Min Revenue beat(4)-8.84%
Max Revenue beat(4)0.89%
Revenue beat(8)6
Avg Revenue beat(8)-0.34%
Revenue beat(12)10
Avg Revenue beat(12)7.45%
Revenue beat(16)14
Avg Revenue beat(16)8.57%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-7.89%
EPS NY rev (1m)0%
EPS NY rev (3m)0.57%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.82%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.45%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.6
P/FCF N/A
P/OCF N/A
P/B 0.55
P/tB 0.66
EV/EBITDA N/A
EPS(TTM)-0.8
EYN/A
EPS(NY)-0.78
Fwd EYN/A
FCF(TTM)-0.61
FCFYN/A
OCF(TTM)-0.56
OCFYN/A
SpS1.75
BVpS5.05
TBVpS4.23
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -14.24%
ROE -16.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 40.41%
FCFM N/A
ROA(3y)1.01%
ROA(5y)-1.05%
ROE(3y)0.93%
ROE(5y)-1.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.22%
GM growth 5Y-6.88%
F-Score2
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 36.29%
Cap/Sales 2.97%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.03
Quick Ratio 6.2
Altman-Z 1.91
F-Score2
WACC9.91%
ROIC/WACCN/A
Cap/Depr(3y)167.19%
Cap/Depr(5y)244.45%
Cap/Sales(3y)7.03%
Cap/Sales(5y)11.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-633.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-216.67%
EPS Next Y-239.35%
EPS Next 2Y-72.67%
EPS Next 3Y-41.36%
EPS Next 5Y25.37%
Revenue 1Y (TTM)-43.95%
Revenue growth 3Y-7.36%
Revenue growth 5Y3.75%
Sales Q2Q%-32.14%
Revenue Next Year-38.37%
Revenue Next 2Y-20.05%
Revenue Next 3Y-11.49%
Revenue Next 5Y-4.62%
EBIT growth 1Y-539.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-91.42%
EBIT Next 3Y-4.37%
EBIT Next 5Y25.91%
FCF growth 1Y-157.36%
FCF growth 3YN/A
FCF growth 5Y117%
OCF growth 1Y-148.56%
OCF growth 3YN/A
OCF growth 5Y22.81%

ORASURE TECHNOLOGIES INC / OSUR FAQ

What is the ChartMill fundamental rating of ORASURE TECHNOLOGIES INC (OSUR) stock?

ChartMill assigns a fundamental rating of 2 / 10 to OSUR.


What is the valuation status of ORASURE TECHNOLOGIES INC (OSUR) stock?

ChartMill assigns a valuation rating of 0 / 10 to ORASURE TECHNOLOGIES INC (OSUR). This can be considered as Overvalued.


Can you provide the profitability details for ORASURE TECHNOLOGIES INC?

ORASURE TECHNOLOGIES INC (OSUR) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for OSUR stock?

The Earnings per Share (EPS) of ORASURE TECHNOLOGIES INC (OSUR) is expected to decline by -239.35% in the next year.